Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
1-Minute Consult

How should we diagnose and manage checkpoint inhibitor-associated colitis?

Freeha Khan, MD, Pauline Funchain, MD, Ana Bennett, MD, Tracy L. Hull, MD and Bo Shen, MD
Cleveland Clinic Journal of Medicine September 2018, 85 (9) 679-683; DOI: https://doi.org/10.3949/ccjm.85a.18020
Freeha Khan
Inflammatory Bowel Disease Fellow, Department of Gastroenterology, Hepatology, & Nutrition, Cleveland Clinic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pauline Funchain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Bennett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tracy L. Hull
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bo Shen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 85 no. 9 679-683
DOI 
https://doi.org/10.3949/ccjm.85a.18020
PubMed 
30192732

Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online September 1, 2018.

Copyright & Usage 
Copyright © 2018 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Freeha Khan, MD
  1. Inflammatory Bowel Disease Fellow, Department of Gastroenterology, Hepatology, & Nutrition, Cleveland Clinic
  1. Pauline Funchain, MD
  1. Department of Hematology and Medical Oncology, Cleveland Clinic
  2. Clinical Assistant Professor Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  1. Ana Bennett, MD
  1. Department of Anatomic Pathology and Transplantation Center, Cleveland Clinic
  2. Clinical Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  1. Tracy L. Hull, MD
  1. Surgical Head, Section of Inflammatory Bowel DIsease, Department of Colorectal Surgery, Cleveland Clinic
  2. Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  1. Bo Shen, MD⇑
  1. Section Head, Center for Inflammatory Bowel Disease, Department of Gastroenterology, Hepatology, & Nutrition, Cleveland Clinic
  2. Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  1. ADDRESS:
    Bo Shen, MD, Center for Inflammatory Bowel Disease, Department of Gastroenterology and Hepatology, A31, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; shenb{at}ccf.org

Cited By...

  • 4 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 85 (9)
Cleveland Clinic Journal of Medicine
Vol. 85, Issue 9
1 Sep 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
How should we diagnose and manage checkpoint inhibitor-associated colitis?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
How should we diagnose and manage checkpoint inhibitor-associated colitis?
Freeha Khan, Pauline Funchain, Ana Bennett, Tracy L. Hull, Bo Shen
Cleveland Clinic Journal of Medicine Sep 2018, 85 (9) 679-683; DOI: 10.3949/ccjm.85a.18020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
How should we diagnose and manage checkpoint inhibitor-associated colitis?
Freeha Khan, Pauline Funchain, Ana Bennett, Tracy L. Hull, Bo Shen
Cleveland Clinic Journal of Medicine Sep 2018, 85 (9) 679-683; DOI: 10.3949/ccjm.85a.18020
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • POWERFUL ANTICANCER DRUGS
    • ICI-ASSOCIATED COLITIS IS COMMON
    • COLITIS IS A SPECTRUM
    • RULE OUT INFECTION
    • CONSIDER COLONOSCOPY AND BIOPSY
    • COMPUTED TOMOGRAPHY CAN BE USEFUL
    • TREATMENT
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • We can learn a lot from drug adverse effects
  • PubMed
  • Google Scholar

Cited By...

  • Reincarnating autoimmunity: Immune-related adverse events as new diseases
  • Incidence of immune checkpoint inhibitor-mediated diarrhea and colitis (imDC) in patients with cancer and preexisting inflammatory bowel disease: a propensity score-matched retrospective study
  • CMV coinfection in treatment refractory immune checkpoint inhibitor colitis
  • Google Scholar

More in this TOC Section

  • What diagnostic tests should be done after discovering clubbing in a patient without cardiopulmonary symptoms?
  • Does my adult patient need a measles vaccine?
  • Do I need to treat supine hypertension in my hospitalized patient?
Show more 1-Minute Consult

Similar Articles

Subjects

  • Drug Therapy
  • Gastroenterology
  • Oncology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire